Acadia Healthcare (NASDAQ:ACHC) Reaches New 12-Month Low on Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price reached a new 52-week low during mid-day trading on Wednesday after Barclays lowered their price target on the stock from $17.00 to $14.00. Barclays currently has an equal weight rating on the stock. Acadia Healthcare traded as low as $12.63 and last traded at $14.3560, with a volume of 3101654 shares traded. The stock had previously closed at $16.49.

Other analysts also recently issued research reports about the stock. Mizuho cut their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a report on Wednesday, August 13th. Deutsche Bank Aktiengesellschaft cut their target price on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday. Guggenheim reduced their target price on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research report on Monday, November 10th. Bank of America cut Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $21.50 to $13.00 in a report on Wednesday. Finally, Leerink Partnrs downgraded Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Eight investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and an average price target of $23.17.

Institutional Trading of Acadia Healthcare

Several hedge funds have recently made changes to their positions in the business. CANADA LIFE ASSURANCE Co grew its holdings in shares of Acadia Healthcare by 38.6% in the third quarter. CANADA LIFE ASSURANCE Co now owns 92,269 shares of the company’s stock valued at $2,264,000 after purchasing an additional 25,710 shares in the last quarter. Verition Fund Management LLC lifted its holdings in Acadia Healthcare by 32.1% during the 3rd quarter. Verition Fund Management LLC now owns 205,620 shares of the company’s stock worth $5,091,000 after buying an additional 50,016 shares in the last quarter. Prelude Capital Management LLC boosted its position in Acadia Healthcare by 78.2% in the 3rd quarter. Prelude Capital Management LLC now owns 69,184 shares of the company’s stock valued at $1,713,000 after buying an additional 30,369 shares during the period. Public Employees Retirement System of Ohio grew its stake in shares of Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after acquiring an additional 867 shares in the last quarter. Finally, Invenomic Capital Management LP increased its position in shares of Acadia Healthcare by 41.6% during the third quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company’s stock worth $47,945,000 after acquiring an additional 568,796 shares during the period.

Acadia Healthcare Stock Performance

The firm has a market capitalization of $1.35 billion, a price-to-earnings ratio of 12.51, a PEG ratio of 3.13 and a beta of 0.91. The firm has a 50 day moving average price of $20.86 and a 200-day moving average price of $21.79. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.01. The company had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.Acadia Healthcare’s revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.